Related Experiment Video
Updated: May 5, 2026
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
IFNγ-stimulated dendritic cell exosomes as a potential therapeutic for remyelination
Aya D Pusic1, Kae M Pusic2, Benjamin L L Clayton1
1Department of Neurology, The University of Chicago, Chicago, IL 60637, USA; Committee on Neurobiology, The University of Chicago, Chicago, IL 60637, USA.
Abstract:
Dendritic cells (DCs) release exosomes with different characteristics based on stimulus. Here, we showed that DC cultures stimulated with low-level IFNγ released exosomes (IFNγ-DC-Exos) that contained microRNA species that can increase baseline myelination, reduce oxidative stress, and improve remyelination following acute lysolecithin-induced demyelination. Furthermore, nasally administered IFNγ-DC-Exos increased CNS myelination in vivo. IFNγ-DC-Exos were preferentially taken up by oligodendrocytes, suggesting that they directly impact oligodendrocytes to increase myelination. Thus, our results show great potential for use of these IFNγ-DC-Exos as a therapeutic to promote remyelination in multiple sclerosis and dysmyelinating syndromes.
Insights
Stimulating dendritic cells (DCs) with interferon-gamma (IFNγ) produces exosomes (IFNγ-DC-Exos) that enhance central nervous system (CNS) myelination and promote remyelination. These exosomes show therapeutic potential for multiple sclerosis and other demyelinating diseases.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Dendritic cells (DCs) release exosomes, which are small extracellular vesicles involved in intercellular communication.
- Exosome characteristics and cargo can be modulated by the stimulus applied to the parent cell.
- Demyelinating diseases, such as multiple sclerosis, are characterized by damage to the myelin sheath in the central nervous system (CNS).
Purpose of the Study:
- To investigate the therapeutic potential of exosomes derived from dendritic cells stimulated with low-level interferon-gamma (IFNγ).
- To determine if these specific exosomes (IFNγ-DC-Exos) can promote myelination and remyelination in the CNS.
- To explore the mechanism by which IFNγ-DC-Exos exert their effects on myelination.
Main Methods:
- Dendritic cell cultures were stimulated with low-level IFNγ.
- Exosomes released from these stimulated DCs (IFNγ-DC-Exos) were isolated and characterized.
- The microRNA content of IFNγ-DC-Exos was analyzed.
- An in vivo model of acute lysolecithin-induced demyelination was used to assess the effects of nasal administration of IFNγ-DC-Exos on CNS myelination.
- Cellular uptake of IFNγ-DC-Exos by oligodendrocytes was investigated.
Main Results:
- IFNγ-DC-Exos contain microRNA species that can increase baseline myelination and reduce oxidative stress.
- Nasal administration of IFNγ-DC-Exos significantly increased CNS myelination in vivo.
- IFNγ-DC-Exos were preferentially taken up by oligodendrocytes, the myelin-producing cells of the CNS.
- IFNγ-DC-Exos treatment improved remyelination following induced demyelination.
Conclusions:
- IFNγ-DC-Exos possess properties that promote myelination and enhance the brain's capacity for remyelination.
- These exosomes directly impact oligodendrocytes, suggesting a targeted therapeutic mechanism.
- IFNγ-DC-Exos represent a promising cell-free therapeutic strategy for treating multiple sclerosis and other dysmyelinating syndromes.
